3Ikeda K, Arase Saitoh S, et al. Long-term outcome of HBV carriers with negative HBe antigen and normal aminotransferase[J] .Am J Med,2006, 119(11) :977.
4M aruyama T, Thornton G, linos, et al. Use of anti peptide antibodies for the desing of antigen specific immune complex assays[ J]. Immunological methods, 1992,155 : 65.
5Okamoto H, Tsuda F, Akahane Y, et al. Hepatitis B vrius mutations in the core Promoter for an antigen-negative phenotype in carriers with antobody to e antigen[J] .J Viral, 1994,68:8102.
2Barrera A,Guerra B, Notvall L,et al. Mapping of the Hepatitis B Virus pre-S1 domain involved in receptor recognition[J]. J Virol, 2005,79 (15) : 9786-9798.
3Bang G, Kim KH, Guarnieri M, et al. Effect of muta- ting the two cysteines required for HBe antigenicity on hepatitis B virus DNA replication and virion secre- tion[J]. Virology, 2005,332 (1) : 216-224.
4Patient R, Hourioux C, Sizaret PY, et al. Hepatitis B virus subviral envelope particle morphogenesis and in- tracellular trafficking[J].J Virol, 2007,81 (8) : 3842- 3851.
5Bruss V. Envelopment of the hepatitis B virus nucleo- capsid[J].Virus Res, 2004,106 (2) : 199-209.
6Gervain J. Significance of the changes in HBV DNA and HBsAg levels during the treatment of chronic hepatitis B[J]. Orv Hetil,2011,152(22) :866-868.
7Liang TJ. Hepatitis B: the virus and disease [J]. Hepatology, 2009,49(5) : 13-21.
8Bruss V,Vieluf K. Functions of the internal pre-S domain of the large surface protein in hepatitis B virus particle morphogenesis [J]. J Virol, 1995,69(11) :6652-6657.
9Gervain J. Significance of the changes in HBV DNA and HBsAg levels during the treatment of chronic hepatitis B[J]. Orv Hetil, 2011,152(22) :866-868.
